- Deerfield, Illinois
- Baxter Ventures invests in patient care companies with innovative technologies and is an Illinois-based investment firm.
Baxter Ventures invests in companies with innovative technologies, products and therapies with the ability to improve patient care globally and maximize value for investors and entrepreneurs. Our focus includes therapeutic areas complementary to those of Baxter's Medical Products and BioScience businesses, as well as cutting-edge technologies and therapies outside of our current product portfolio that have sustainable long-term growth potential.
As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to develop products and therapies that advance patient care worldwide.
|Jun, 2016||Kit Check||$15M / Series C (Lead)||—|
|Oct, 2015||Opsonix, Inc.||$8M / Series A (Lead)||—|
|Oct, 2015||TVA Medical||$15M / Series C (Lead)||—|
|Sep, 2015||SANIFIT||€36.6M / Series C||—|
|May, 2015||Precision BioSciences||$25.65M / Series A||—|
|Apr, 2015||Mirna Therapeutics||$41.8M / Series D (Lead)||—|
|Apr, 2015||True North Therapeutics||$35M / Series B||—|
|Dec, 2014||Naurex||$80M / Series C||—|
|Jun, 2014||True North Therapeutics||$22M / Series A||—|
|Feb, 2014||Covagen||$2.81M / Series B||—|
|Dec, 2013||Covagen||$47.2M / Series B||—|
|Dec, 2012||Regado Biosciences||$51M / Series E||—|
|Jun 20, 2016||Boston Tech Flash - D.C. medication-tracking company closes $15M funding round led by Baxter, Kaiser|
|May 24, 2016||PRWeb Sitemap - Baxter Ventures joins Medasense Biometrics Ltd. Series B Financing|
|Sep 8, 2015||WSJ Blogs - The Daily Startup: CFO Who Took Twitter Public Lands at Docker|
|Jun 17, 2014||Xconomy - With $22M, True North Points Toward Rare-Disease Clinical Trials|
Baxter International Inc.
One Baxter Parkway
Deerfield, Illinois 60015